FBIO
Price
$1.63
Change
+$0.05 (+3.16%)
Updated
Oct 11 closing price
PGEN
Price
$0.90
Change
+$0.07 (+8.43%)
Updated
Oct 11 closing price
30 days until earnings call
Ad is loading...

FBIO vs PGEN

Header iconFBIO vs PGEN Comparison
Open Charts FBIO vs PGENBanner chart's image
Fortress Biotech
Price$1.63
Change+$0.05 (+3.16%)
Volume$479.12K
CapitalizationN/A
Precigen
Price$0.90
Change+$0.07 (+8.43%)
Volume$529.56K
CapitalizationN/A
View a ticker or compare two or three
FBIO vs PGEN Comparison Chart
Loading...
FBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
FBIO vs. PGEN commentary
Oct 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBIO is a StrongSell and PGEN is a StrongSell.

COMPARISON
Comparison
Oct 14, 2024
Stock price -- (FBIO: $1.63 vs. PGEN: $0.90)
Brand notoriety: FBIO and PGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FBIO: 91% vs. PGEN: 51%
Market capitalization -- FBIO: $39.91M vs. PGEN: $276.99M
FBIO [@Biotechnology] is valued at $39.91M. PGEN’s [@Biotechnology] market capitalization is $276.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FBIO’s FA Score shows that 1 FA rating(s) are green whilePGEN’s FA Score has 0 green FA rating(s).

  • FBIO’s FA Score: 1 green, 4 red.
  • PGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, FBIO is a better buy in the long-term than PGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FBIO’s TA Score shows that 5 TA indicator(s) are bullish while PGEN’s TA Score has 4 bullish TA indicator(s).

  • FBIO’s TA Score: 5 bullish, 4 bearish.
  • PGEN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both FBIO and PGEN are a good buy in the short-term.

Price Growth

FBIO (@Biotechnology) experienced а 0.00% price change this week, while PGEN (@Biotechnology) price change was -0.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

FBIO is expected to report earnings on Mar 27, 2024.

PGEN is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PGEN($277M) has a higher market cap than FBIO($39.9M). PGEN YTD gains are higher at: -32.940 vs. FBIO (-45.847). FBIO has higher annual earnings (EBITDA): -93.31M vs. PGEN (-130.97M). FBIO has more cash in the bank: 76.2M vs. PGEN (19.5M). PGEN has less debt than FBIO: PGEN (6.34M) vs FBIO (88.4M). FBIO has higher revenues than PGEN: FBIO (82.6M) vs PGEN (4.39M).
FBIOPGENFBIO / PGEN
Capitalization39.9M277M14%
EBITDA-93.31M-130.97M71%
Gain YTD-45.847-32.940139%
P/E RatioN/AN/A-
Revenue82.6M4.39M1,882%
Total Cash76.2M19.5M391%
Total Debt88.4M6.34M1,394%
FUNDAMENTALS RATINGS
FBIO vs PGEN: Fundamental Ratings
FBIO
PGEN
OUTLOOK RATING
1..100
762
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
63
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
8287
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a9

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FBIO's Valuation (32) in the Biotechnology industry is in the same range as PGEN (63) in the null industry. This means that FBIO’s stock grew similarly to PGEN’s over the last 12 months.

FBIO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PGEN (100) in the null industry. This means that FBIO’s stock grew similarly to PGEN’s over the last 12 months.

PGEN's SMR Rating (98) in the null industry is in the same range as FBIO (100) in the Biotechnology industry. This means that PGEN’s stock grew similarly to FBIO’s over the last 12 months.

FBIO's Price Growth Rating (82) in the Biotechnology industry is in the same range as PGEN (87) in the null industry. This means that FBIO’s stock grew similarly to PGEN’s over the last 12 months.

FBIO's P/E Growth Rating (100) in the Biotechnology industry is in the same range as PGEN (100) in the null industry. This means that FBIO’s stock grew similarly to PGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FBIOPGEN
RSI
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
69%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
85%
Bullish Trend 13 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
FBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY579.583.45
+0.60%
SPDR® S&P 500® ETF Trust
GME20.83-0.08
-0.38%
GameStop Corp
BTC.X62851.375000-341.648440
-0.54%
Bitcoin cryptocurrency
AAPL227.55-1.49
-0.65%
Apple
TSLA217.80-20.97
-8.78%
Tesla

FBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBIO has been loosely correlated with SEER. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if FBIO jumps, then SEER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBIO
1D Price
Change %
FBIO100%
+3.16%
SEER - FBIO
40%
Loosely correlated
+3.13%
BEAM - FBIO
38%
Loosely correlated
+7.34%
AXON - FBIO
38%
Loosely correlated
+1.45%
NTLA - FBIO
38%
Loosely correlated
+4.44%
EDIT - FBIO
37%
Loosely correlated
+7.77%
More